Ten years of proteomics in multiple sclerosis (Q38171465)

30 August 2017

Ten years of proteomics in multiple sclerosis (English)

1 reference

30 August 2017

0 references

Alessandro S Farias

1

0 references

Daniel Martins-de-Souza

object named as

Daniel Martins-de-Souza

5

0 references

Andrea Schmitt

object named as

Andrea Schmitt

3

0 references

author name string

Fernando Pradella

2

1 reference

PubMed ID

24339438

30 August 2017

Leonilda M B Santos

4

1 reference

30 August 2017

1 March 2014

1 reference

30 August 2017

1 reference

30 August 2017

14

1 reference

30 August 2017

4-5

1 reference

30 August 2017

467-480

1 reference

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

30 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Multiple sclerosis: is there neurodegeneration independent from inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Immunomodulatory treatment strategies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Progressive multiple sclerosis: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Genome-wide association study of severity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Genetics of multiple sclerosis: swimming in an ocean of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Regional DTI differences in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Gray matter involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

The distribution of plaques in the cerebrum in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

The origin and application of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Granulocyte-colony-stimulating factor treatment enhances Foxp3(+) T lymphocytes and modifies the proinflammatory response in experimental autoimmune neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Regulatory T cells and inhibitory cytokines in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Pathogenetic role of autoantibodies in neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteomic technologies for biomarker studies in psychiatry: advances and needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteomics technologies for the global identification and quantification of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Prostaglandins and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Antigen processing and presentation by the class I major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Cerebrospinal fluid biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Autoantibody profiling in multiple sclerosis using arrays of human protein fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Apolipoprotein e sets the stage: response to injury triggers neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

APOE genotype-specific differences in the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Reactive astrocytes in neural repair and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Potassium channel KIR4.1 as an immune target in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteomic analysis of multiple sclerosis cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Comprehensive tissue processing strategy for quantitative proteomics of formalin-fixed multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: A pilot study on relation to clinical findings and brain atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Analysis of the mitochondrial proteome in multiple sclerosis cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

New antigenic candidates in multiple sclerosis: identification by serological proteome analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Proteome analysis of brain in murine experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Cerebrospinal fluid proteome profile in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Genomewide Study of Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201300268

21 January 2018

Identifiers

DOI

10.1002/PMIC.201300268

1 reference

30 August 2017

1 reference

PubMed ID

24339438